10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $379,995 | -26.1% | 9,212 | 0.0% | 0.07% | -12.9% |
| Q2 2023 | $514,398 | +35.3% | 9,212 | +35.1% | 0.08% | +23.2% |
| Q1 2023 | $380,320 | +6.8% | 6,817 | -30.2% | 0.07% | +7.8% |
| Q4 2022 | $356,055 | +28.1% | 9,771 | 0.0% | 0.06% | +10.3% |
| Q3 2022 | $278,000 | -37.9% | 9,771 | -1.3% | 0.06% | -37.0% |
| Q2 2022 | $448,000 | -40.5% | 9,903 | 0.0% | 0.09% | -28.7% |
| Q1 2022 | $753,000 | -48.9% | 9,903 | 0.0% | 0.13% | -50.4% |
| Q4 2021 | $1,475,000 | +3.7% | 9,903 | +1.4% | 0.26% | +14.0% |
| Q3 2021 | $1,422,000 | -21.2% | 9,771 | +6.0% | 0.23% | -20.3% |
| Q2 2021 | $1,805,000 | +23.2% | 9,217 | -13.6% | 0.29% | +11.3% |
| Q1 2021 | $1,465,000 | +97.4% | 10,672 | +103.5% | 0.26% | +123.5% |
| Q4 2020 | $742,000 | +124.8% | 5,243 | +98.1% | 0.12% | +79.7% |
| Q3 2020 | $330,000 | – | 2,646 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |